IDSI will select new distributors for the UAE and intends to secure prospective sales of the CTLM system based on leads from the RSNA 2008 conference.
"Arab Health is an important show for us, especially this year, as we will continue to build our distributor network in the middle east and for the first time demonstrate the CTLM system at the booth to those who may not be familiar with the modality," stated Deborah O'Brien/Senior Vice President of Imaging Diagnostic.
The Arab Health exhibition and congress is the region's premier event for the Middle East, bringing healthcare manufacturers, wholesalers, dealers and distributors together with some of the most important and influential decision-makers in the Arab world.
With the market in the UAE becoming more competitive and buying cycles in both the public and private sectors increasing, Arab Health 2009 is an ideal opportunity for companies to display their latest technology and equipment. As one of the largest and most prestigious healthcare events in the Middle East, with over 3,000 exhibitors from over 65 countries and more than 60,000 medical professionals, it is recognized as the global show, and for many companies, the one event, to attend in the exhibition calendar year.
Browse
related articles
Imaging Diagnostic Systems exhibits at Arab Health 2009
- United Arab Emirates: Wednesday, January 28 - 2009 at 16:37
- PRESS RELEASE
Imaging Diagnostic Systems, Inc., a pioneer in laser optical breast imaging exhibits the CT Laser Mammography (CTLM(R)) system at the Arab Health 2009 medical conference, January 26-29, 2009, in Dubai, United Arab Emirates (UAE).
Also consider reading:
Digg
Facebook
LinkedIn
Twitter
Browse
related articles
Log in to request more information from Imaging Diagnostic Systems
Notes and media contacts
About Imaging Diagnostic Systems, Inc.:Imaging Diagnostic Systems, Inc. has developed a revolutionary new imaging device to aid in the detection and management of breast cancer. The CTLM(R) system is a breast imaging system that utilizes patented continuous wave laser technology and computer algorithms to create 3-D images of the breast.
The procedure is non-invasive, painless, and does not expose the patient to ionizing radiation or painful breast compression. CT Laser Mammography (CTLM(R)) is designed to be used in conjunction with mammography. It reveals information about blood distribution in the breast and may visualize the process of angiogenesis, which usually accompanies tumor growth.
The Company is currently collecting clinical data for the Pre-market approval application in hopes to gain FDA marketing clearance in the United States. The FDA has determined that the Company's clinical study is a non-significant risk (NSR) investigational device study under 812.3(m) of the investigational device exemptions (IDE) regulation (21 CFR 812). The CTLM system is limited by United States Federal Law to investigational use only in the United States.
For more information, please contact:
Deborah O'Brien
Imaging Diagnostic Systems, Inc
Tel:+1-954-257-8940
Posted by Rana MesbahWednesday, January 28 - 2009 at 16:37 UAE local time (GMT+4)
Replication or redistribution in whole or in part is expressly prohibited without the prior written consent of AME Info FZ LLC / Emap Limited.
Disclaimer:
Articles in this section are primarily provided directly by the companies appearing or PR agencies which are solely responsible for the content. The companies concerned may use the above content on their respective web sites provided they link back to http://www.ameinfo.com
Any opinions, advice, statements, offers or other information expressed in this section of the AMEinfo.com Web site are those of the authors and do not necessarily reflect the views of AME Info FZ LLC / Emap Limited. AME Info FZ LLC / Emap Limited is not responsible or liable for the content, accuracy or reliability of any material, advice, opinion or statement in this section of the AMEinfo.com Web site.
For details about submitting your stories, please read the guide - all content published is subject to our terms and conditions
It looks like you are using a Mac - check out our 
Web Feeds